Coverage
Pharma & biotech
KOLs, former regulators, and clinical investigators who've been inside the therapeutic area you're studying, not adjacent to it.
Expert types
Common use cases
Pipeline & mechanism diligence
Validate a therapeutic mechanism or competitive pipeline read with practicing specialists in the relevant indication.
Regulatory pathway assessment
Get a former reviewer's perspective on approval strategy, trial design, or likely agency questions.
Launch readiness
Stress-test commercial and access assumptions with brand leads who've run comparable launches.
Competitive positioning
Understand how prescribers actually weigh your asset against the standard of care.
Questions we help answer
“How will oncologists actually sequence this drug relative to the current standard of care?”
“What would make the FDA push back on this trial design, based on precedent?”
“Is the KOL enthusiasm at conferences translating into real prescribing intent?”
“What did the competitor's Phase 2 readout actually tell prescribers, versus what the press release said?”
In practice
An investor needed to know whether oncologists would really switch regimens on a competitor's Phase 2 readout, or whether the market was overreacting to a press release. We sourced three practicing oncologists across academic and community settings within three business days, scoped around prescribing behavior rather than trial mechanics, and came back with a split view by practice setting that looked nothing like the market's first reaction.
Composite example, illustrative only.
How we deliver this
Who this serves